RCSB PDB
US$ 24.86
glutathione cancer resistance Managing GSH elevation and hypoxia to overcome of therapies using functionalized nanocarriers Glutathione Depletion and Stalwart Anticancer
Description
This sudden release can lead to suboptimal drug concentrations at the intended target site in the body, diminishing the drugs therapeutic effect [339]
Most comparison guides frame this as a head-to-head efficacy contest
Mitochondria, oxidants, and aging
Apteff, 43 , 1-342
10.1016/j.neuropharm.2015.11.011 Neuropharmacology
ISSN:0028-0836
